In cancer cells, MYC has been implicated as a key positive regulator of CAP-dependent mRNA translation (Cargnello and Topisirovic, 2019), a process that was predicted to be downregulated upon Mettl3 ablation in embryonc skin. This evidence concerns the gene METTL3 and cancer.